Inovio Pharmaceuticals (INO) Stock Price, Quote, News & History | Benzinga

Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, News & History

INONASDAQ

Trade with Public

Trade with Public

$1.18

-0.01-0.84%

At close: Apr 20, 5:00 PM EST

$1.20

0.021.69%

After Hours: 4:00 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.20

Close

$1.18

Volume / Avg.

1.97M / 1.56M

Day Range

$1.17 - $1.21

52 Wk Range

1.03 - 2.98

Market Cap

$97.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

13.84%

Days to Cover

12.04

Recent Inovio Pharmaceuticals Inc News

What's Going On With Inovio Pharmaceuticals Stock On Tuesday?

Inovio prices a $17.5 million share offering, narrows losses, cuts expenses, and advances INO-3107 under FDA review.

Vandana Singh

What's Behind The Drop In Inovio Pharmaceuticals Stock Today?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares are tumbling Thursday after the company announced the pricing of a proposed public offering.

Alex Perry

Inovio Stock Up On Earnings, Pipeline Progress

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher on Friday morning after the company reported fourth-quarter results.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-88.63M

Investing Cash Flow (TTM)

14.04M

Financing Cash Flow (TTM)

53.05M

Free Cash Flow (TTM)

-88.92M

Capital Expenditure (TTM)

-285.70K

Net Change in Cash (TTM)

-21.54M

Analyst Trends and Forecast

1

Nov 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$48.36M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

857.46

PB Ratio (TTM)

4.05

Earnings Yield % (TTM)

-151.46%

Earnings Yield % (FWD)

-79.92%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.30

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$44.27M

Debt to Equity

0.39

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

$0

Key Statistics

Open

$1.20

Close

$1.18

Volume / Avg.

1.97M / 1.56M

Day Range

$1.17 - $1.21

52 Wk Range

1.03 - 2.98

Market Cap

$97.91M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

38

Short Interest

13.84%

Days to Cover

12.04

About

Sector

Health Care

Industry

Biotechnology

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. IN...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Inovio Pharmaceuticals (INO) stock?

A

You can purchase shares of Inovio Pharmaceuticals (NASDAQ:INO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Inovio Pharmaceuticals (INO) competitors?

A

Other companies in Inovio Pharmaceuticals’s space includes: InflaRx NV (NASDAQ:IFRX), Anixa Biosciences Inc (NASDAQ:ANIX), Gain Therapeutics Inc (NASDAQ:GANX), Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) and PepGen Inc (NASDAQ:PEPG).

Q

What is the forecast, or price target, for Inovio Pharmaceuticals (INO) stock?

A

Inovio Pharmaceuticals has a consensus price target of $15.38.

Q

What is the current price for Inovio Pharmaceuticals (INO)?

A

The stock price for Inovio Pharmaceuticals (NASDAQ: INO) is $1.2 last updated April 20, 2026 at 4:00 PM EDT.

Q

Does Inovio Pharmaceuticals (INO) pay a dividend?

A

There are no upcoming dividends for Inovio Pharmaceuticals.

Q

When is Inovio Pharmaceuticals (NASDAQ:INO) reporting earnings?

A

Inovio Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Inovio Pharmaceuticals (INO) going to split?

A

There is no upcoming split for Inovio Pharmaceuticals.

Q

What sector and industry does Inovio Pharmaceuticals (INO) operate in?

A

Inovio Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Anixa Biosciences Inc

Gain Therapeutics Inc

Coeptis Therapeutics Holdings Inc

Forum Markets Inc

MAIA Biotechnology Inc

Sangamo Therapeutics Inc